Medicare Enrolled

Dr. Linda Leventhal, M.D.

Dermatology · Yardley, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
385 OXFORD VALLEY RD, Yardley, PA 19067
2153213500
In practice since 2006 (20 years)
NPI: 1831147776 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leventhal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leventhal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leventhal

Dr. Linda Leventhal is a dermatology specialist in Yardley, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leventhal performed 1,700 Medicare services across 1,216 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leventhal received a total of $5,050 from 28 pharmaceutical and/or device companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leventhal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,700 Medicare services $5,050 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,700
Medicare services
Bottom 48% in PA for dermatology
1,216
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
430 $5 $12
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
403 $57 $141
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
242 $40 $115
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
213 $36 $86
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
107 $77 $156
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
66 $29 $149
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
55 $71 $183
Destruction of skin growth, 15 or more growths 50 $83 $186
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
34 $126 $255
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
22 $126 $307
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
21 $36 $130
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
17 $71 $192
Shaving of skin growth on face, 0.6-1.0 cm
This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters.
14 $89 $153
Shaving of skin growth, 1.1-2.0 cm
This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs.
13 $95 $268
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
13 $108 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$5,050
Total received (2018-2023)
Avg $1,010/year across 5 years
Top 29% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
228
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,050 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$641
2022
$836
2020
$97
2019
$1,715
2018
$1,761

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$163
Novartis Pharmaceuticals Corporation
$115
Lilly USA, LLC
$72
ABBVIE INC.
$68
Janssen Biotech, Inc.
$66
GENZYME CORPORATION
$50
Regeneron Healthcare Solutions, Inc.
$33
Sun Pharmaceutical Industries Inc.
$25
Arcutis Biotherapeutics, Inc.
$20
Dermavant Sciences, Inc.
$15
PFIZER INC.
$15
Top 3 companies account for 54.7% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$917
Janssen Biotech, Inc.
$732
Lilly USA, LLC
$477
Celgene Corporation
$454
Sun Pharmaceutical Industries Inc.
$272
AbbVie, Inc.
$255
Regeneron Healthcare Solutions, Inc.
$253
GENZYME CORPORATION
$224
Galderma Laboratories, L.P.
$200
Almirall LLC
$191
Amgen Inc.
$163
ABBVIE INC.
$133
Mayne Pharma Inc.
$111
PFIZER INC.
$92
Ortho Dermatologics, a division of Bausch Health US, LLC
$89
Promius Pharma LLC
$68
Mission Pharmacal Company
$65
Encore Dermatology Inc.
$61
UCB, Inc.
$61
Dermavant Sciences, Inc.
$43
Sebela Pharmaceuticals Inc.
$38
EPI Health, LLC
$34
Exeltis, USA Inc.
$30
Arcutis Biotherapeutics, Inc.
$20
Journey Medical Corporation
$19
MAYNE PHARMA INC.
$18
Allergan Inc.
$18
Sandoz Inc.
$11
Top 3 companies account for 42.1% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · AKLIEF · Aczone · Avar · BOTOX COSMETIC · CLODERM · COSENTYX · Cimzia · Cloderm Cream · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · EPIDUO FORTE · EUCRISA · Ecoza · Exelderm · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · KERYDIN · NAFTIN · ONEXTON · ORACEA · Otezla · PRAMOSONE · RETIN-A-MICRO · SILIQ · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · TALTZ · TREMFYA · TRIANEX 0.05% · Tremfya · ULTRAVATE · VTAMA · Veltin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Yardley?
Compare dermatologists in the Yardley area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
171
Per 100K population
26.5
County median income
$111,951
Nearest hospital
ST MARY MEDICAL CENTER
4.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Leventhal is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Leventhal experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Leventhal performed 430 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leventhal receive payments from pharmaceutical companies?
Yes. Dr. Leventhal received a total of $5,050 from 28 companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leventhal's costs compare to other dermatologists in Yardley?
Dr. Leventhal's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leventhal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →